mND

mND quantifies gene relevance in multi-omics datasets by propagating molecular alteration signals across biological networks using a multi-layer network diffusion framework.


Key Features:

  • Network Diffusion Approach: Employs network diffusion to assess gene relevance by considering gene proximity and interactions with neighboring genes within biological networks.
  • Gene Score (mND): Implements a gene score (mND) that quantifies a gene's relevance based on its network position and its first neighbors' proximity to other altered genes.
  • Performance: Shows improved performance compared to existing methods in identifying genes altered in one or more omics layers and in recovering known cancer-related genes.
  • Flexibility and Applicability: Processes diverse input types including multi-omics datasets and stratified classes such as cell clusters derived from single-cell analyses.

Scientific Applications:

  • Disease Research: Provides insights into molecular events associated with human diseases to support understanding of disease mechanisms and identification of potential therapeutic targets.
  • Oncology: Facilitates cancer genomics research by recovering known cancer genes and analysing gene interactions relevant to oncological studies.

Methodology:

Integrates multi-layer data inputs with network-based analysis and quantifies gene relevance via a diffusion process across biological networks.

Topics

Details

Tool Type:
web application
Programming Languages:
R
Added:
11/14/2019
Last Updated:
11/24/2024

Operations

Publications

Di Nanni N, Gnocchi M, Moscatelli M, Milanesi L, Mosca E. Gene relevance based on multiple evidences in complex networks. Bioinformatics. 2019;36(3):865-871. doi:10.1093/bioinformatics/btz652. PMID:31504182. PMCID:PMC9883679.

PMID: 31504182
PMCID: PMC9883679
Funding: - Italian Ministry of Education, University and Research: Flagship InterOmics PB05, PRIN 2015 20157ATSLF, PON ELIXIR CNR-BIOmics PIR01_00017, GR-2016-02363997, Italian Ministry of Health - Fondazione Regionale per la Ricerca Biomedica: ERAPERMED2018-233 GA 779282, LYRA 2015 0010 - European Union’s Horizon 2020: 825033